We are live on ! Find out more
ABBV icon

AbbVie
ABBV

3,821 hedge funds and large institutions have $270B invested in AbbVie in 2025 Q1 according to their latest regulatory filings, with 264 funds opening new positions, 1,495 increasing their positions, 1,622 reducing their positions, and 125 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more first-time investments, than exits

New positions opened: 264 | Existing positions closed: 125

47% more funds holding in top 10

Funds holding in top 10: 167 → 246 (+79)

16% more capital invested

Capital invested by funds: $233B → $270B (+$37.3B)

15% more call options, than puts

Call options by funds: $3.94B | Put options by funds: $3.43B

2% more funds holding

Funds holding: 3,746 → 3,821 (+75)

0.51% more ownership

Funds ownership: 72.32% → 72.82% (+0.51%)

8% less repeat investments, than reductions

Existing positions increased: 1,495 | Existing positions reduced: 1,622

Holders
3,821
Holders Change
+75
Holders Change %
+2%
% of All Funds
51.21%
Holding in Top 10
246
Holding in Top 10 Change
+79
Holding in Top 10 Change %
+47.31%
% of All Funds
3.3%
New
264
Increased
1,495
Reduced
1,622
Closed
125
Calls
$3.94B
Puts
$3.43B
Net Calls
+$502M
Net Calls Change
+$310M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.08B
2
BlackRock
BlackRock
New York
+$747M
3
JP Morgan Chase
JP Morgan Chase
New York
+$582M
4
Goldman Sachs
Goldman Sachs
New York
+$555M
5
Barclays
Barclays
United Kingdom
+$531M

Top Sellers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
-$1.55B
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$583M
3
Charles Schwab
Charles Schwab
California
-$422M
4
Amundi
Amundi
France
-$328M
5
Marshall Wace
Marshall Wace
United Kingdom
-$260M
Name Holding Trade Value Shares
Change 		Change in
Stake
CWAG
1651
Compton Wealth Advisory Group
Virginia
$2.4M +$8.16K +42 +0.4%
GW
1652
Griffith & Werner
Georgia
$2.4M +$121K +621 +6%
CC
1653
Cadinha & Co
Hawaii
$2.4M +$1.75K +9 +0.1%
AIM
1654
Athena Investment Management
California
$2.39M – – –
RCG
1655
Regatta Capital Group
California
$2.38M -$50.5K -260 -2%
RSA
1656
River Street Advisors
Illinois
$2.37M +$99.7K +513 +5%
PTC
1657
Provident Trust Company
Wisconsin
$2.37M – – –
ITIM
1658
Indiana Trust & Investment Management
Indiana
$2.37M – – –
CAM
1659
Councilmark Asset Management
Tennessee
$2.37M – – –
NCM
1660
Northside Capital Management
Oregon
$2.36M +$17.9K +92 +0.8%
CCM
1661
Collar Capital Management
Wisconsin
$2.35M +$792K +4,076 +57%
WTB
1662
Washington Trust Bank
Washington
$2.35M -$563K -2,895 -21%
BFC
1663
Bedel Financial Consulting
Indiana
$2.35M +$13K +67 +0.5%
PPWP
1664
Premier Path Wealth Partners
New Jersey
$2.35M +$149K +769 +7%
FWM
1665
Forza Wealth Management
Florida
$2.35M – – –
BCP
1666
Blackhawk Capital Partners
Wisconsin
$2.35M -$15.7K -81 -0.7%
WCBA
1667
Weaver C. Barksdale & Associates
Tennessee
$2.34M -$49.8K -256 -2%
MIA
1668
MMBG Investment Advisors
Florida
$2.34M – – –
A
1669
AlphaQuest
New York
$2.34M +$1.96M +10,085 +942%
OFS
1670
OneAscent Financial Services
Alabama
$2.34M +$181K +932 +9%
WCM
1671
Westend Capital Management
California
$2.33M +$2.16M +11,097 +34,678%
FDS
1672
Freedom Day Solutions
Texas
$2.32M -$105K -539 -5%
BFA
1673
Beaumont Financial Advisors
Massachusetts
$2.32M +$72.1K +371 +3%
ADL
1674
Asset Dedication LLC
California
$2.32M -$147K -758 -6%
MSWM
1675
McGlone Suttner Wealth Management
Wisconsin
$2.31M +$159K +818 +8%
65 66
67
68 69

ABBV Hedge Fund Activity: Q1 2025 in Review

3,821 of the 7,461 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q1 2025, worth a combined $270B — up 16% from $233B a quarter earlier.

Buyers outnumbered sellers: 264 funds opened new ABBV positions and 125 closed out — a net gain of 139 holders — while 1,495 added to existing stakes and 1,622 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $1.08B. The largest seller was Capital International Investors, cutting an estimated $1.55B.

  • 3,821 institutional investors held AbbVie (ABBV) as of Q1 2025, up from 3,746 in Q4 2024.
  • Funds reported $270B of AbbVie stock for Q1 2025, up 16% quarter-over-quarter.
  • 264 funds opened new AbbVie positions in Q1 2025 and 125 closed out, a net change of +139 holders.
  • The largest AbbVie buyer in Q1 2025 was Fidelity Investments, an estimated $1.08B added.
  • The largest AbbVie seller in Q1 2025 was Capital International Investors, an estimated $1.55B sold.

Based on aggregated 13F filings for Q1 2025.